Dr. Franciscus Leebeek, MD, Ph.D.
Claim this profileErasmus Medisch Centrum
More about Franciscus Leebeek, MD, Ph.D.
Clinical Trial Related
6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Franciscus Leebeek, MD, Ph.D. has experience with
- RFVIII
- RVWF
Breakdown of trials Franciscus Leebeek, MD, Ph.D. has run
Von Willebrand Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Franciscus Leebeek, MD, Ph.D. specialize in?
Franciscus Leebeek, MD, Ph.D. focuses on Von Willebrand Disease and other conditions. In particular, much of their work with Von Willebrand Disease has involved treating patients, or patients who are undergoing treatment.
Is Franciscus Leebeek, MD, Ph.D. currently recruiting for clinical trials?
No, Franciscus Leebeek, MD, Ph.D. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Franciscus Leebeek, MD, Ph.D. has studied deeply?
Yes, Franciscus Leebeek, MD, Ph.D. has studied treatments such as rFVIII, rVWF.
What is the best way to schedule an appointment with Franciscus Leebeek, MD, Ph.D.?
Apply for one of the trials that Franciscus Leebeek, MD, Ph.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.